Hispanic Heritage Month and Psychedelics
Celebrate National Hispanic Heritage Month by expressing gratitude for Hispanic and Latinx visionaries, researchers, community members, and others who have expanded awareness about psychedelics. Taking …
Participant Safety in Psychedelic Therapy
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MAPS PBC) are committed to providing quality and comprehensive training and supervision …
MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: May 9, 2022 The second, confirmatory Phase 3 trial of MDMA-assisted therapy for PTSD is now fully enrolled at 13 sites in the United States and Israel Completion of enrollment on …
Participant Enrolled in Phase 2, Open-Label, Randomized Comparative Effectiveness Study for MDMA-Assisted Therapy in U.S. Military Veterans with Chronic PTSD
As of April 15, 2022, the second and third participants are screening for treatment in the MAPS-sponsored Phase 2, open-label study of the comparative effectiveness of two vs. three MDMA-assisted therapy …
FDA Continues Clinical Hold for Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans (MPG1)
On April 15, 2022, the U.S. Food and Drug Administration (FDA) upheld a partial clinical hold on Study MPG1, preventing the study from being initiated. FDA did not address specific questions from the previous …
March 2022 Giving Report: Donors Give Over $285,000 to Psychedelic Research and Education
In March 2022, over 1,200 donors gave $285,690 in donations and pledges. We are so grateful to these supporters who advance our shared vision of creating safe and legal opportunities for the beneficial …
Investigator-Initiated Trials: April 2022 Update
We are excited to share recent progress with our investigator-initiated trial (IIT) program! The MAPS Public Benefit Corporation (MAPS PBC) IIT program is designed to create an ever-growing network of …
MDMA Therapy Training Program Update: April 2022
In April 2022, we launched our first 100-hour blended (online/in person) training program and hosted a week-long in-person training retreat in North Carolina (pictured above). We welcomed over 75 trainees …
Long-Term Follow Up Study of MDMA-Assisted Therapy for PTSD
Enrollment is continuing for our long-term follow up study for our MDMA-assisted therapy parent studies. The long-term follow up study is open to individuals who participated and received MDMA in at least …
Celebrating the 36th Anniversary of MAPS
On April 8, 1986—36 years ago today—the Multidisciplinary Association for Psychedelic Studies (MAPS) was founded by Rick Doblin, Ph.D., as a non-profit organization to fulfill the need to broaden psychedelic …
The Zendo Project Volunteer Application for Burning Man Now Open
The Zendo Project is excited to provide psychedelic peer support services for the 9th year at Burning Man 2022 in Black Rock City, Nevada! We’ve added new questions to our volunteer application, so please …
MAPS Places Fully Validated, Multi-Kilogram Synthesis of MDMA in the Public Domain
MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices The availability of larger quantities …